Rare diseases
Investigational molecules
Locations
56 Dongpangyo-Ro, Bundang-Gu, 13535
Aribio Co. Ltd. focuses its clinical research on early Alzheimer’s disease, with an emphasis on treatment strategies intended to address cognitive decline and disease-related impairment in the earliest symptomatic stages.
The sponsor’s research activity is centered on therapeutic development within neurology and central nervous system disorders, particularly conditions associated with progressive memory and functional deterioration.
Aribio Co. Ltd. runs clinical trials in conditions such as Dementia Alzheimer's type, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
CzechiaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
